» Articles » PMID: 32295188

Coronavirus Diseases (COVID-19) Current Status and Future Perspectives: A Narrative Review

Overview
Publisher MDPI
Date 2020 Apr 17
PMID 32295188
Citations 215
Authors
Affiliations
Soon will be listed here.
Abstract

At the end of 2019 a novel virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing severe acute respiratory syndrome expanded globally from Wuhan, China. In March 2020 the World Health Organization declared the SARS-Cov-2 virus a global pandemic. We performed a narrative review to describe existing literature with regard to Corona Virus Disease 2019 (COVID-19) epidemiology, pathophysiology, diagnosis, management and future perspective. MEDLINE, EMBASE and Scopus databases were searched for relevant articles. Although only when the pandemic ends it will be possible to assess the full health, social and economic impact of this global disaster, this review represents a picture of the current state of the art. In particular, we focus on public health impact, pathophysiology and clinical manifestations, diagnosis, case management, emergency response and preparedness.

Citing Articles

Spatio-temporal distribution of COVID-19 cases and tuberculosis in four provinces of Sumatra Islands, Indonesia.

Saputra A, Wichaidit W, Kesuma Z, Chongsuvivatwong V BMC Public Health. 2025; 25(1):529.

PMID: 39930380 PMC: 11809051. DOI: 10.1186/s12889-025-21754-z.


Herbal Medicines as Complementary Therapy for Managing Complications in COVID-19 Patients with Diabetes Mellitus.

Adha S, Afifah N, Latarissa I, Iftinan G, Kusuma A, Febriyanti R Diabetes Metab Syndr Obes. 2025; 18():135-146.

PMID: 39840393 PMC: 11746946. DOI: 10.2147/DMSO.S498774.


Protein Interaction Analysis and Molecular Simulation of the Anti-Inflammatory Activities in Extract Against COVID-19.

Tjiptaningrum A, Kurniati I, Fadilah F, Susantiningsih T, Prawiningrum A, Utari W Int J Inflam. 2024; 2024:5568294.

PMID: 39640429 PMC: 11620808. DOI: 10.1155/ijin/5568294.


Feline Infectious Peritonitis Effusion Index: A Novel Diagnostic Method and Validation of Flow Cytometry-Based Delta Total Nucleated Cells Analysis on the Sysmex XN-1000V.

Lopes R, Sampaio F, Carvalho H, Garces A, Fernandes C, Neves C Vet Sci. 2024; 11(11).

PMID: 39591337 PMC: 11598915. DOI: 10.3390/vetsci11110563.


Microfluidic Immunoarray for Point-of-Care Detection of Cytokines in COVID-19 Patients.

Bhalerao K, De Silva P, Hiniduma K, Grunbaum A, Rozza N, Kremer R ACS Omega. 2024; 9(27):29320-29330.

PMID: 39005811 PMC: 11238202. DOI: 10.1021/acsomega.4c00735.


References
1.
Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M . Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020; 30(3):269-271. PMC: 7054408. DOI: 10.1038/s41422-020-0282-0. View

2.
Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P . In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020; 71(15):732-739. PMC: 7108130. DOI: 10.1093/cid/ciaa237. View

3.
Lupia T, Scabini S, Mornese Pinna S, Di Perri G, De Rosa F, Corcione S . 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge. J Glob Antimicrob Resist. 2020; 21:22-27. PMC: 7102618. DOI: 10.1016/j.jgar.2020.02.021. View

4.
Yin Y, Wunderink R . MERS, SARS and other coronaviruses as causes of pneumonia. Respirology. 2017; 23(2):130-137. PMC: 7169239. DOI: 10.1111/resp.13196. View

5.
Lim J, Jeon S, Shin H, Kim M, Seong Y, Lee W . Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative RT-PCR. J Korean Med Sci. 2020; 35(6):e79. PMC: 7025910. DOI: 10.3346/jkms.2020.35.e79. View